eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 10/04/2012
PIL Actilyse

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 12/08/2009 and displayed until 10/04/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 20/08/2008 and displayed until 12/08/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 21/01/2008 and displayed until 20/08/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 21/12/2007 and displayed until 21/01/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 28/11/2007 and displayed until 21/12/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/06/2007 and displayed until 28/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 10/01/2003 and displayed until 08/06/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 06/12/2000 and displayed until 10/01/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   alteplase